Subject: Washington University School of Medicine and Barnes-Jewish Hospital patients not at risk from steroid injections with meningitis
The FDA is investigating an outbreak of meningitis resulting from a fungal-contaminated steroid produced and distributed by the New England Compounding Center in Framingham, Massachusetts. Barnes-Jewish Hospital and Washington University School of Medicine have not purchased any products from this manufacturer.
Physicians of the WUSM/BJH Pain Management Center wish to reassure you of the safety of our patients. The meningitis outbreak shouldn’t cast a harsh light on epidural injections themselves.
A large multidisciplinary pain center such as ours has varied treatment options, medical and non-medical. Steroid injections are one of many options. As board-certified pain specialists, we value the use of steroid injections in treating chronic and acute back pain. Even short-term relief can prove invaluable in stimulating long-term treatment, which often involves exercise and other physical therapy.
If you have any concerns, our physicians and staff are available to speak with you. We can be reached at 314-362-8820.
Robert A. Swarm, MD, Chief, Clinical Pain Management
Rahul Rastogi, MD, Associate Professor of Anesthesiology
Michael Bottros, MD, Instructor in Anesthesiology
Bakul Dave, MD, Assistant Professor of Anesthesiology
Beverly Field, PhD, Associate Professor of Psychiatry and Anesthesiology
Anthony Guarino, MD, Associate Professor of Anesthesiology
Lesley Rao, MD, Instructor in Anesthesiology
Xiaobin Yi, MD, Assistant Professor of Anesthesiology